Drug Shortage Report for PYRIDOXINE HYDROCHLORIDE INJECTION, USP

Last updated on 2024-01-10 History
Report ID 213767
Drug Identification Number 02245215
Brand name PYRIDOXINE HYDROCHLORIDE INJECTION, USP
Common or Proper name PYRIDOXINE HYDROCHLORIDE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) PYRIDOXINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 30 ML Vial
ATC code A11HA
ATC description OTHER PLAIN VITAMIN PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-01-10
Actual start date
Estimated end date Unknown
Actual end date 2024-01-02
Shortage status Avoided shortage
Updated date 2024-01-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-01-10 French Compare
v3 2024-01-10 English Compare
v2 2023-12-19 French Compare
v1 2023-12-19 English Compare

Showing 1 to 4 of 4